|
|
| Line 14: |
Line 14: |
|
| |
|
| ===Age=== | | ===Age=== |
| *Patients of all age groups may develop [disease name]. | | *Adolescent an early adulthood. |
| *The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
| |
| *[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
| |
| *[Chronic disease name] is usually first diagnosed among [age group].
| |
| *[Acute disease name] commonly affects [age group].
| |
| | |
| ===Race===
| |
| *There is no racial predilection to [disease name].
| |
| *[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
| |
| ===Gender=== | | ===Gender=== |
| *[Disease name] affects men and women equally. | | *[Disease name] affects men and women equally. |
| *[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1. | | *[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1. |
| ===Region===
| |
| *The majority of [disease name] cases are reported in [geographical region].
| |
|
| |
| *[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
| |
|
| |
| ===Developed Countries===
| |
|
| |
| ===Developing Countries===
| |
| There are no established risk factors for [disease name].
| |
|
| |
| OR
| |
|
| |
| The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
| |
|
| |
| OR
| |
|
| |
| Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
| |
|
| |
| OR
| |
|
| |
| Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
| |
| ==Risk Factors==
| |
| *There are no established risk factors for [disease name].
| |
| OR
| |
| *The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
| |
|
| |
| *Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
| |
| ===Common Risk Factors===
| |
| *Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
| |
| *Common risk factors in the development of [disease name] include:
| |
| **[Risk factor 1]
| |
| **[Risk factor 2]
| |
| **[Risk factor 3]
| |
|
| |
| ===Less Common Risk Factors===
| |
| *Less common risk factors in the development of [disease name] include:
| |
| **[Risk factor 1]
| |
| **[Risk factor 2]
| |
| **[Risk factor 3]
| |
|
| |
|
|
| |
|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Hamid Qazi, MD, BSc [2]
Overview
Epidemiology and Demographics
Prevalence
- The prevalence of Peutz-Jeghers syndrome is estimated to be 1 in 25000 to 30000
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Adolescent an early adulthood.
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
References